Corts Trust for JC Penney Debentures
Change company Symbol lookup
Select an option...
COTRP Corts Trust for JC Penney Debentures
PVL Permianville Royalty Trust
FUPBY Fuchs Petrolub SE
JACK Jack in the Box Inc
NH NantHealth Inc
PWSC PowerSchool Holdings Inc
AEHL Antelope Enterprise Holdings Ltd
POR Portland General Electric Co
CUBI Customers Bancorp Inc

Day's Change
0.00 (0.00%)
B/A Size
Day's High
Day's Low

Today's volume of 150 shares is on pace to be much lighter than COTRP's 10-day average volume of 1,047 shares.


FDA grants priority review to Reata's rare disease drug

2:31 pm ET May 26, 2022 (MarketWatch)

Shares of Reata Pharmaceuticals Inc. (RETA) were up 2.4% in trading on Thursday after the company said the Food and Drug Administration granted priority review to the company's experimental treatment for Friedreich's ataxia, a rare nervous system disease. The regulator is now set to make a decision on omaveloxolone by Nov. 30. "If approved, we are looking forward to a commercial launch in early 2023," Reata CEO Warren Huff said in a news release. Reata's stock is up 4.3% so far this year, while the S&P 500 is down 16.5%

-Jaimy Lee


(END) Dow Jones Newswires

May 26, 2022 14:31 ET (18:31 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.